IP Library Assignment 072384/0781
Patent Assignment
Reel/Frame 072384/0781

Security Interest

Recorded: 2025-09-26 Pages: 11
Assignors
HARROW, INC.
Executed: 2025-09-26
HARROW IP, LLC
Executed: 2025-09-26
Assignee
FIFTH THIRD BANK, NATIONAL ASSOCIATION, AS AGENT
6111 N. RIVER RD., ROSEMONT, ILLINOIS, 60018
Covered Properties (39)
Three Layer Artificial Tear Formulation
Patent: 7,758,883 →
Application: 10/688,539 →
Publication: US 2004/0142038
Topical Nepafenac Formulations
Patent: 7,834,059 →
Application: 11/292,484 →
Publication: US 2006/0122277
Ophthalmic Compositions Containing a Synergistic Combination of Two Polymers
Patent: 7,947,295 →
Application: 11/673,070 →
Publication: US 2007/0128156
Topical Ophthalmic Compositions Containing Tobramycin and Dexamethasone
Patent: 7,795,316 →
Application: 11/960,196 →
Low Viscosity, Highly Flocculated Triamcinolone Acetonide Suspensions for Intravitreal Injection
Patent: 8,128,960 →
Application: 12/401,168 →
Publication: US 2009/0233890
Pharmaceutical Compositions Containing a Fluoroquinolone Antibiotic Drug
Patent: 8,450,311 →
Application: 12/474,307 →
Publication: US 2009/0306128
Topical Ophthalmic Compositions Containing Tobramycin and Dexamethasone
Patent: 8,101,582 →
Application: 12/841,414 →
Publication: US 2010/0286078
Topical Nepafenac Formulations
Patent: 8,071,648 →
Application: 12/888,631 →
Publication: US 2011/0015271
Carboxyvinyl Polymer-Containing Nanoparticle Suspensions
Patent: 8,921,337 →
Application: 12/957,864 →
Publication: US 2011/0135743
Topical Nepafenac Formulations
Patent: 8,324,281 →
Application: 13/253,648 →
Publication: US 2012/0029084
Topical Ophthalmic Compositions Containing Tobramycin and Dexamethasone
Patent: 8,450,287 →
Application: 13/311,716 →
Publication: US 2012/0077769
Low Viscosity, Highly Flocculated Triamcinolone Acetonide Suspensions for Intravitreal Injection
Patent: 8,211,880 →
Application: 13/352,009 →
Publication: US 2012/0116216
Pharmaceutical Formulations of Xanthine or Xanthine Derivatives, and Their Use
Patent: 9,849,133 →
Application: 14/307,773 →
Publication: US 2015/0017151
Pharmaceutical Formulations of Tranexamic Acid and Their Use
Patent: 9,301,936 →
Application: 14/325,630 →
Publication: US 2015/0038406
Epinephrine-Based Ophthalmic Compositions for Intraocular Administration and Methods for Fabricating Thereof
Application: 14/506,120 →
Publication: US 2015/0119440
Carboxylvinyl Polymer-Containing Nanoparticle Suspensions
Patent: 9,662,398 →
Application: 14/539,996 →
Publication: US 2015/0072011
Intraocular Lens Comprising Pharmaceutical Compositions and Methods for Fabricating Thereof
Patent: 9,814,673 →
Application: 15/066,731 →
Publication: US 2016/0193144
Epinephrine-Based Ophthalmic Compositions for Intraocular Administration and Methods for Fabricating Thereof
Application: 15/247,524 →
Publication: US 2017/0049721
Pharmaceutical Compositions Comprising Gels and Methods for Fabricating Thereof
Application: 15/395,830 →
Publication: US 2017/0105931
Pharmaceutical Formulations of Xanthine or Xanthine Derivatives, and Their Use
Application: 15/620,430 →
Publication: US 2017/0319590
Epinephrine-Based Ophthalmic Compositions for Intraocular Administration and Methods for Fabricating Thereof
Application: 15/685,702 →
Publication: US 2018/0055790
Anti-Fungal Compositions for Treating Nails and Methods for Fabricating and Using Thereof
Application: 16/026,542 →
Publication: US 2018/0311188
Adrenocorticotropic Hormone-Based Pharmaceutical Formulations and Methods for Fabricating and Using Thereof
Application: 16/250,711 →
Publication: US 2019/0134163
Pyrimethamine-Based Pharmaceutical Compositions and Methods for Fabricating Thereof
Application: 16/433,679 →
Publication: US 2019/0374540
Pharmaceutical Formulations for the Treatment of Dry Eye and Methods for Fabricating and Using Thereof
Application: 16/523,059 →
Publication: US 2020/0030334
Adrenocorticotropic Hormone-Based Pharmaceutical Formulations and Methods for Fabricating and Using Thereof
Application: 16/774,415 →
Publication: US 2020/0155651
Pyrimethamine-Based Pharmaceutical Compositions and Methods for Fabricating Thereof
Application: 16/852,954 →
Publication: US 2020/0246287
Pharmaceutical Formulations for the Treatment of Dry Eye and Methods for Fabricating and Using Thereof
Application: 16/871,692 →
Publication: US 2020/0268763
Ocular Lubricant Formulations
Application: 17/268,256 →
Publication: US 2021/0315924
Epinephrine-Based Ophthalmic Compositions for Intraocular Administration and Methods for Fabricating Thereof
Application: 17/384,373 →
Publication: US 2021/0346318
Methods and System for Remotely Capturing Media via a User Interface Bidirectionally Linked to a Remote Server
Application: 17/747,616 →
Publication: US 2022/0374075
Methods for Increasing Shelf-Life of Ophthalmic Pharmaceutical Compositions
Application: 17/881,092 →
Publication: US 2023/0050398
Antibacterial Compositions and Methods for Fabricating Thereof
Application: 18/019,580 →
Publication: US 2023/0302032
Ophthalmic Dye Composition and Method for Administering Same
Application: 18/117,126 →
Publication: US 2023/0277694
Mydriatic Compositions and Methods for Fabricating Thereof
Application: 18/266,491 →
Publication: US 2024/0058320
Ocular Lubricant Formulations
Application: 18/594,231 →
Publication: US 2024/0197773
Methods and System for Remotely Capturing Media via a User Interface Bidirectionally Linked to a Remote Server
Application: 18/748,848 →
Publication: US 2024/0338074
Extended-Release Pharmaceutical Compositions for Treating Eye Conditions
Application: 18/827,095 →
Publication: US 2024/0423970
Extended-Release Pharmaceutical Compositions for Treating Eye Conditions
Application: 18/844,789 →
Publication: US 2025/0186415
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 2, 2010
From: ALCON RESEARCH, LTD.
To: ALCON, INC.
Reel/Frame 023883/0651 →
Assignment of Assignor's Interest Jul 11, 2013
From: NOVARTIS AG
To: ALCON PHARMACEUTICALS LTD.
Reel/Frame 030781/0375 →
Assignment of Assignor's Interest Aug 28, 2014
From: BUDERER, MATTHEW J.; ABRAMS, JEFFREY J.
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 033630/0620 →
Assignment of Assignor's Interest Aug 28, 2014
From: BUDERER, MATTHEW J.
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 033630/0592 →
Assignment of Assignor's Interest Oct 24, 2014
From: KAROLCHYK, JOHN SCOTT; BAUM, MARK L.
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 034025/0070 →
Security Interest Jun 16, 2015
From: IMPRIMIS PHARMACEUTICALS, INC.
To: IMMY FUNDING LLC
Reel/Frame 035923/0749 →
Assignment of Assignor's Interest Mar 3, 2016
From: NOVARTIS AG
To: ALCON RESEARCH LTD.
Reel/Frame 037886/0357 →
Assignment of Assignor's Interest Apr 6, 2016
From: SEELHORST, GARY; HARVEY, THOMAS; BAUM, MARK L.
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 038210/0122 →
Release of Security Interest in Intellectual Property Collateral at Reel/Frame No. 35923/0749 Jul 19, 2017
From: IMMY FUNDING LLC
To: IMPRIMIS PHARMACEUTICALS, INC.
Reel/Frame 043259/0434 →
Intellectual Property Security Agreement Jul 19, 2017
From: IMPRIMIS PHARMACEUTICALS, INC.
To: SWK FUNDING LLC, AS COLLATERAL AGENT
Reel/Frame 043258/0581 →
Assignment of Assignor's Interest Jul 27, 2017
From: IMPRIMIS PHARMACEUTICALS, INC.
To: ETON PHARMACEUTICALS, INC.
Reel/Frame 043120/0957 →
Assignment of Assignor's Interest Jul 9, 2018
From: AQUEOUS PHARMA LIMITED
To: FOCUS LABORATORIES, INC.
Reel/Frame 046293/0160 →
Assignment of Assignor's Interest Dec 5, 2018
From: FOCUS LABORATORIES, INC.
To: EYEVANCE PHARMACEUTICALS LLC
Reel/Frame 047677/0824 →
Change of Name Jan 4, 2019
From: IMPRIMIS PHARMACEUTICALS, INC.
To: HARROW HEALTH, INC.
Reel/Frame 048013/0368 →
Assignment of Assignor's Interest Jun 7, 2019
From: ETON PHARMACEUTICALS, INC.
To: HARROW IP, LLC
Reel/Frame 049402/0589 →
Merger Oct 16, 2019
From: ALCON RESEARCH, LTD.
To: ALCON RESEARCH, LLC
Reel/Frame 050735/0465 →
Confirmatory Deed of Assignment Effective April 8, 2019 Oct 17, 2019
From: ALCON RESEARCH, LLC
To: NOVARTIS AG
Reel/Frame 050746/0431 →
Security Interest Oct 17, 2019
From: EYEVANCE PHARMACEUTICALS LLC, AS GRANTOR
To: HAYFIN SERVICES LLP, AS COLLATERAL AGENT
Reel/Frame 050751/0051 →
Corrective Assignment to Correct the Assignee Address. Previously Recorded at Reel: 050746 Frame: 0431. Assignor(S) Hereby Confirms the Assignment.. Oct 18, 2019
From: ALCON RESEARCH, LLC
To: NOVARTIS AG
Reel/Frame 050767/0001 →
Assignment of Assignor's Interest Oct 21, 2019
From: NOVARTIS AG
To: EYEVANCE PHARMACEUTICALS LLC
Reel/Frame 050778/0977 →
Security Interest Oct 25, 2019
From: EYEVANCE PHARMACEUTICALS LLC
To: HAYFIN SERVICES LLP, AS COLLATERAL AGENT
Reel/Frame 050832/0028 →
Assignment of Assignor's Interest Nov 1, 2019
From: HARROW HEALTH, INC.
To: HARROW IP, LLC
Reel/Frame 050903/0404 →
Assignment of Assignor's Interest Nov 12, 2019
From: IMPRIMIS PHARMACEUTICALS, INC.
To: HARROW IP, LLC
Reel/Frame 050985/0969 →
Amended and Restated Intellectual Property Security Agreement Nov 21, 2019
From: HARROW IP, LLC
To: SWK FUNDING LLC, AS COLLATERAL AGENT
Reel/Frame 051079/0453 →
Confirmatory Deed of Assignment Effective April 8, 2019 Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →